| 000 | 01614 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250513204945.0 | ||
| 264 | 0 | _c20000512 | |
| 008 | 200005s 0 0 eng d | ||
| 022 | _a0014-4827 | ||
| 024 | 7 |
_a10.1006/excr.1999.4778 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLin, C W | |
| 245 | 0 | 0 |
_aDifferential expression of human topoisomerase IIIalpha during the cell cycle progression in HL-60 leukemia cells and human peripheral blood lymphocytes. _h[electronic resource] |
| 260 |
_bExperimental cell research _cApr 2000 |
||
| 300 |
_a225-36 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 | _aAmino Acid Sequence |
| 650 | 0 | 4 | _aAntibodies |
| 650 | 0 | 4 |
_aCell Cycle _xphysiology |
| 650 | 0 | 4 |
_aCell Differentiation _xdrug effects |
| 650 | 0 | 4 |
_aCell Nucleolus _xenzymology |
| 650 | 0 | 4 |
_aCell Nucleus _xmetabolism |
| 650 | 0 | 4 | _aCells, Cultured |
| 650 | 0 | 4 |
_aDNA Topoisomerases, Type I _xanalysis |
| 650 | 0 | 4 |
_aDimethyl Sulfoxide _xpharmacology |
| 650 | 0 | 4 |
_aGranulocytes _xenzymology |
| 650 | 0 | 4 | _aHL-60 Cells |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aLymphocyte Activation |
| 650 | 0 | 4 |
_aLymphocytes _xcytology |
| 650 | 0 | 4 | _aMolecular Sequence Data |
| 650 | 0 | 4 |
_aPeptide Fragments _xchemistry |
| 650 | 0 | 4 | _aPhotolysis |
| 700 | 1 | _aDarzynkiewicz, Z | |
| 700 | 1 | _aLi, X | |
| 700 | 1 | _aTraganos, F | |
| 700 | 1 | _aBedner, E | |
| 700 | 1 | _aTse-Dinh, Y C | |
| 773 | 0 |
_tExperimental cell research _gvol. 256 _gno. 1 _gp. 225-36 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1006/excr.1999.4778 _zAvailable from publisher's website |
| 999 |
_c10693129 _d10693129 |
||